These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 31232712)
41. Metabolic Acidosis in Chronic Kidney Disease: Pathogenesis, Clinical Consequences, and Treatment. Kim HJ Electrolyte Blood Press; 2021 Dec; 19(2):29-37. PubMed ID: 35003283 [TBL] [Abstract][Full Text] [Related]
42. Sodium bicarbonate therapy in patients with metabolic acidosis. Adeva-Andany MM; Fernández-Fernández C; Mouriño-Bayolo D; Castro-Quintela E; Domínguez-Montero A ScientificWorldJournal; 2014; 2014():627673. PubMed ID: 25405229 [TBL] [Abstract][Full Text] [Related]
43. Assessment of the Potential for Veverimer Drug-Drug Interactions. Parsell D; Shao J; Guttendorf R; Mathur V; Li E; Wu YS; Tsao L; Tabakman S; Stasiv Y; Lee A; Biyani K; Klaerner G Drug Metab Dispos; 2021 Jul; 49(7):490-500. PubMed ID: 34031138 [TBL] [Abstract][Full Text] [Related]
44. In older adults with CKD and mild acidosis, oral sodium bicarbonate did not improve physical function. Kohn OF Ann Intern Med; 2020 Nov; 173(10):JC56. PubMed ID: 33197344 [TBL] [Abstract][Full Text] [Related]
45. Effects of correcting metabolic acidosis on muscle mass and functionality in chronic kidney disease: a systematic review and meta-analysis. Visser WJ; van de Braak EEM; de Mik-van Egmond AME; van der Burgh AC; de Roos NM; Jans I; van der Hoef I; Olieman JF; Hoorn EJ; Severs D J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2498-2508. PubMed ID: 37728018 [TBL] [Abstract][Full Text] [Related]
48. Recent evidence on the effect of treatment of metabolic acid on the progression of kidney disease. Hultin S; Johnson DW; Badve SV Curr Opin Nephrol Hypertens; 2021 Sep; 30(5):467-473. PubMed ID: 34009141 [TBL] [Abstract][Full Text] [Related]
49. Management of the Metabolic Acidosis of Chronic Kidney Disease. Goraya N; Wesson DE Adv Chronic Kidney Dis; 2017 Sep; 24(5):298-304. PubMed ID: 29031356 [TBL] [Abstract][Full Text] [Related]
50. Effects of Oral Bicarbonate Supplementation on the Cardiovascular Risk Factors and Serum Nutritional Markers in Non-Dialysed Chronic Kidney Disease Patients. Szczecińska K; Wajdlich M; Nowicka M; Nowicki M; Kurnatowska I Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454357 [TBL] [Abstract][Full Text] [Related]
51. Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate. Goraya N; Munoz-Maldonado Y; Simoni J; Wesson DE Am J Nephrol; 2019; 49(6):438-448. PubMed ID: 30995657 [TBL] [Abstract][Full Text] [Related]
52. Sodium Bicarbonate Treatment and Vascular Function in CKD: A Randomized, Double-Blind, Placebo-Controlled Trial. Kendrick J; You Z; Andrews E; Farmer-Bailey H; Moreau K; Chonchol M; Steele C; Wang W; Nowak KL; Patel N J Am Soc Nephrol; 2023 Aug; 34(8):1433-1444. PubMed ID: 37228030 [TBL] [Abstract][Full Text] [Related]
53. Does correction of metabolic acidosis slow chronic kidney disease progression? Goraya N; Wesson DE Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803 [TBL] [Abstract][Full Text] [Related]
54. [Screening and management of metabolic acidosis in patients with chronic kidney disease]. Georges B; Huart J; Krzesinski JM; Jouret F Rev Med Suisse; 2018 Aug; 14(615):1455-1458. PubMed ID: 30136461 [TBL] [Abstract][Full Text] [Related]
55. Very Low-Protein Diet (VLPD) Reduces Metabolic Acidosis in Subjects with Chronic Kidney Disease: The "Nutritional Light Signal" of the Renal Acid Load. Di Iorio BR; Di Micco L; Marzocco S; De Simone E; De Blasio A; Sirico ML; Nardone L; Nutrients; 2017 Jan; 9(1):. PubMed ID: 28106712 [TBL] [Abstract][Full Text] [Related]
56. Diagnosis and Treatment of Metabolic Acidosis in Patients with Chronic Kidney Disease - Position Statement of the Working Group of the Polish Society of Nephrology. Adamczak M; Masajtis-Zagajewska A; Mazanowska O; Madziarska K; Stompór T; Więcek A Kidney Blood Press Res; 2018; 43(3):959-969. PubMed ID: 29895022 [TBL] [Abstract][Full Text] [Related]
57. Metabolic Acidosis of CKD: An Update. Kraut JA; Madias NE Am J Kidney Dis; 2016 Feb; 67(2):307-17. PubMed ID: 26477665 [TBL] [Abstract][Full Text] [Related]
58. The Prevalence and Management of Metabolic Acidosis of Chronic Kidney Disease. Ahmed AR; Satti MM; Abdalla AE; Giblin L; Lappin D Ir Med J; 2019 Oct; 112(9):1002. PubMed ID: 31651132 [TBL] [Abstract][Full Text] [Related]
59. Reno-protective effects of oral alkalizing agents in chronic kidney disease with aciduria: protocol for a randomized cohort study. Abe M; Akaishi T; Shoji M; Yamaguchi T; Miki T; Satoh F; Takayama S; Yamasaki S; Kawaguchi K; Sato H; Ishii T; Ito S; BMC Nephrol; 2020 Apr; 21(1):144. PubMed ID: 32321450 [TBL] [Abstract][Full Text] [Related]
60. Bicarbonate Supplement Restores Urinary Klotho Excretion in Chronic Kidney Disease: A Pilot Study. Hage V; Villain C; Pelletier S; Laville M; Drai J; Fouque D J Ren Nutr; 2019 Jul; 29(4):285-288. PubMed ID: 30581063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]